Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-23-015177)

Filing Details

Accession Number:: 0000899243-23-015177
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-06-09 16:15:17
Reporting Period:: 2023-06-08

Accepted Time:: 2023-06-09 16:15:17
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1733257	Finch Therapeutics Group Inc.	FNCH	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1577637	E Susan Graf	C/O Finch Therapeutics Group, Inc. 75 State Street, Suite 100 Boston MA 02109		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-06-09	5,010	$0.27	5,010	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Acquisiton	2023-06-08	10,000	$0.00	10,000	$0.29

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
10,000		2033-06-07	No	4	A	Direct

Footnotes

The shares subject to this option shall vest in twelve equal monthly installments beginning on July 8, 2023, subject to the Reporting Person continuing to provide service through each such date.